Antibacterial |
AgNPs are used in coatings and textiles to inhibit bacterial infections, especially against antibiotic-resistant strains. |
AgNPs, in combination with antibiotics, enhance effectiveness against multidrug-resistant bacterial infections. |
In vitro |
[235,236,237,238,239,240] |
Antiviral |
AgNPs demonstrate antiviral capabilities against viruses such as coronaviruses, HIV-1, influenza, herpes simplex, and hepatitis B. |
AgNPs act as virucidal agents and show synergistic effects with antiviral drugs such as oseltamivir against H1N1. |
In vitro |
[215,241,242,243] |
Antibiofilm |
AgNPs are incorporated into coatings to prevent biofilm formation and disrupt established biofilms. |
Effective against antibiotic-resistant bacteria biofilms, such as those formed by Staphylococcus aureus and Escherichia coli. |
In vitro |
[200,244,245,246,247,248] |
Antifungal |
AgNPs exhibit antifungal properties against various fungi, including those causing plant diseases and infections in immunocompromised individuals. |
Used to treat drug-resistant fungal infections and enhance the effectiveness of antifungal treatments. |
In vitro |
[38,40,246,247,249,250,251,252,253] |
Antiparasitic |
AgNPs show potential against parasites such as malaria vectors, leishmaniasis, and Acanthamoeba. |
Demonstrate efficacy against parasites at different lifecycle stages when produced using various green synthesis methods. |
In vitro |
[254,255,256,257,258,259,260,261,262] |
Anticancer and Antitumor |
AgNPs induce cytotoxicity in cancer cells and enhance targeted drug delivery. |
Used alone or with other anticancer drugs, they increase the therapeutic efficacy of treatments such as chemotherapy. |
In vitro |
[5,263,264,265,266] |
Food Industry |
AgNPs are used in the food industry for their antibacterial properties, including food packaging, coatings, and films to prevent food spoilage and contamination. |
AgNPs enhance the antimicrobial properties of food packaging materials, helping to prevent the growth of drug-resistant bacteria in food products. |
In vitro |
[267,268,269,270,271,272] |
Drug Delivery |
AgNPs improve drug stability and bioavailability, offering controlled release for enhanced treatment efficacy. |
Can penetrate biological barriers, such as the blood-brain barrier, facilitating targeted drug delivery. |
In vitro |
[5,273] |
Medical Implants |
AgNPs are used to coat medical implants, enhancing their antibacterial properties and longevity. |
Reduce infection rates in implanted devices, show minimal cytotoxicity, and promote osseointegration. |
In vitro |
[274,275,276,277,278] |
Surface Coatings |
AgNPs in surface coatings offer antibacterial properties and thermal enhancements, effectively fighting bacteria in air and water… |
AgNPs enhance the antibacterial properties of surfaces, including porous titanium, and can modify surfaces for better microbial resistance. |
In vitro |
[99,279,280,281,282,283,284,285] |
Dentistry and dental industry |
AgNPs are utilized in dental materials to prevent biofilm formation, crucial for oral health. |
Improve antibacterial properties in various dental applications, supporting sterile environments. |
In vitro and In vivo |
[244,286,287,288,289] |